These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12637241)
1. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241 [TBL] [Abstract][Full Text] [Related]
2. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM; Wester MR; Aramsombatdee E; Raucy JL Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596 [TBL] [Abstract][Full Text] [Related]
3. Novel Cytochrome P450 2C94 Functionally Metabolizes Diclofenac and Omeprazole in Dogs. Uno Y; Morikuni S; Shiraishi M; Asano A; Murayama N; Yamazaki H Drug Metab Dispos; 2023 May; 51(5):637-644. PubMed ID: 36754837 [TBL] [Abstract][Full Text] [Related]
4. Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450. Shou M; Norcross R; Sandig G; Lu P; Li Y; Lin Y; Mei Q; Rodrigues AD; Rushmore TH Drug Metab Dispos; 2003 Sep; 31(9):1161-9. PubMed ID: 12920172 [TBL] [Abstract][Full Text] [Related]
5. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A). Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554 [TBL] [Abstract][Full Text] [Related]
6. Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor. VandenBranden M; Ring BJ; Binkley SN; Wrighton SA Pharmacogenetics; 1996 Feb; 6(1):81-91. PubMed ID: 8845864 [TBL] [Abstract][Full Text] [Related]
7. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation. Yasumori T; Li QH; Yamazoe Y; Ueda M; Tsuzuki T; Kato R Pharmacogenetics; 1994 Dec; 4(6):323-31. PubMed ID: 7704038 [TBL] [Abstract][Full Text] [Related]
8. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms. Coller JK; Somogyi AA; Bochner F Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492 [TBL] [Abstract][Full Text] [Related]
9. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related]
10. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. Zhao K; Ding M; Cao H; Cao ZX J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175 [TBL] [Abstract][Full Text] [Related]
11. Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro. Liu KH; Kim MJ; Shon JH; Moon YS; Seol SY; Kang W; Cha IJ; Shin JG Xenobiotica; 2005 Jan; 35(1):27-38. PubMed ID: 15788366 [TBL] [Abstract][Full Text] [Related]
12. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. Chiba K; Kobayashi K; Manabe K; Tani M; Kamataki T; Ishizaki T J Pharmacol Exp Ther; 1993 Jul; 266(1):52-9. PubMed ID: 8331574 [TBL] [Abstract][Full Text] [Related]
13. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744 [TBL] [Abstract][Full Text] [Related]
14. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. Goldstein JA; Faletto MB; Romkes-Sparks M; Sullivan T; Kitareewan S; Raucy JL; Lasker JM; Ghanayem BI Biochemistry; 1994 Feb; 33(7):1743-52. PubMed ID: 8110777 [TBL] [Abstract][Full Text] [Related]
15. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
16. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Karam WG; Goldstein JA; Lasker JM; Ghanayem BI Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508 [TBL] [Abstract][Full Text] [Related]
17. Metabolic characterization of the major human small intestinal cytochrome p450s. Obach RS; Zhang QY; Dunbar D; Kaminsky LS Drug Metab Dispos; 2001 Mar; 29(3):347-52. PubMed ID: 11181505 [TBL] [Abstract][Full Text] [Related]
18. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Pharm Sci; 1998 Jul; 87(7):845-53. PubMed ID: 9649353 [TBL] [Abstract][Full Text] [Related]
19. Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability. Martinez SE; Shi J; Zhu HJ; Perez Jimenez TE; Zhu Z; Court MH Drug Metab Dispos; 2019 Nov; 47(11):1314-1324. PubMed ID: 31427433 [TBL] [Abstract][Full Text] [Related]
20. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]